New research into the ’‘stop’ brain chemical could improve treatment of such conditions as attention deficit hyperactivity disorder (ADHD).
The first University of Cambridge-National Institutes of Health Scholars Colloquium was held on June 30. The Scholars Programme is a special interdisciplinary programme committed to scholarship in the training of exceptional students in various areas of basic biomedical research or clinical research, leading to a Doctor of Philosophy degree awarded by the University of Cambridge.
Nobel Prize winning scientist Professor Joshua Lederberg will open a unique disease research facility in Cambridge on Monday 28 June.
Professor Joshua Lederberg, Professor-Emeritus of Molecular Genetics and Informatics at Rockefeller University, will be speaking at the Sackler Distinguished Lecture at the School of Clinical Medicine about the evolutionary competition of humans with microbial species.
Leading pharmaceuticals company Merck Sharp &amp; Dohme (MSD) have recently entered into a new educational sponsorship agreement to give a further &pound;1.5m to the University to support the training of future neuroscientists at Cambridge.